Recent News

• 09.10.2025 - Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 09.10.2025 - Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 09.10.2025 - Please visit again. “Live at Congress” is currently under construction. While we work to add content, we invite you to browse and explore other sections of our website. Thank you for your patience! The Gossamer Bio Team.
• 09.03.2025 - Cantor Global Healthcare Conference
• 09.03.2025 - Cantor Global Healthcare Conference
• 08.29.2025 - Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study
• 08.29.2025 - Gossamer Bio to Present at Upcoming Investor Conferences
• 08.29.2025 - Gossamer Bio to Present at Upcoming Investor Conferences
• 08.07.2025 - Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 08.07.2025 - Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 08.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.05.2025 - 8-K Current report
• 08.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.05.2025 - EX-99.1 EX-99.1
• 07.29.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 07.17.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors